NCT01716975 Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy Status COMPLETED Phase PHASE3
NCT01716858 An Open Study of Sulforaphane-rich Broccoli Sprout Extract in Patients With Schizophrenia Status COMPLETED Phase PHASE2
NCT01714713 A 26-Week Extension Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy Status COMPLETED Phase PHASE3
NCT01714661 Study of EVP-6124 (Alpha-7 nAChR) as an Adjunctive Pro-Cognitive Treatment in Schizophrenia Subjects on Chronic Stable Atypical Antipsychotic Therapy Status COMPLETED Phase PHASE3
NCT01714011 Safety and Efficacy of Aripiprazole and Ziprasidone Among Schizophrenic Patients With Metabolic Syndrome Status COMPLETED Phase PHASE4
NCT01712646 Daily Intranasal Oxytocin for Childhood-Onset Schizophrenia Status TERMINATED Phase PHASE1/PHASE2
NCT01706965 Kuvan in People With Schizophrenia and Schizoaffective Disorder Status COMPLETED Phase PHASE1/PHASE2
NCT01698216 Switching From Consta® to Sustenna® in Patients With Schizophrenia Status COMPLETED Phase N/A
NCT01689389 Description of the Use of Quetiapine Extended Release (XR) in Real-life Practice in France. An Observational Study Status COMPLETED Phase N/A
NCT01685931 A Study of Paliperidone Palmitate in Patients With Schizophrenia Previously Unsuccessfully Treated by Oral Antipsychotics Status COMPLETED Phase PHASE4
NCT01683058 Open-label, Extension Study of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in Patients With Schizophrenia Status COMPLETED Phase PHASE3
NCT01682161 A Comparative Study to Evaluate the Evolution of Medication Satisfaction and Adherence in Patients Unsatisfied With Current Oral Atypical Antipsychotics by Switching Medication to Paliperidone Palmitate Status COMPLETED Phase PHASE4
NCT01678755 A Phase 2 Study to Evaluate ABT-126 for the Treatment of Cognitive Deficits in Schizophrenia Status COMPLETED Phase PHASE2
NCT01677377 Multiple Ascending Dose Study of the Safety, Tolerability, Pharmacokinetic/Efficacy Status COMPLETED Phase PHASE2